NIH-funded research R01 grant

Injectable biomaterials to help the brain heal after stroke

Official title: BRAIN (Biomimetic Regenerative Angiogenic Immunomodulating Nanocomposite) materials for brain repair after stroke

Funded at University of Nevada Las Vegas · NIH-11370045 · Data updated 2026-11-12

An injectable brain-like material designed to grow new blood vessels and reduce inflammation to help adults recover after a stroke.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nevada Las Vegas
NIH-funded
Lab location1 site (Las Vegas, United States)
Project startJanuary 1, 2022
Project endDecember 31, 2028
Funding year2026
Award (this year)$460,877
NIH project number5R01NS121150-04
Project IDNIH-11370045 on NIH RePORTER

Who could benefit from this research

Could help

Adults with acquired brain injury from stroke who are medically stable and meet the trial's timing, lesion-size, and safety criteria would be the likely candidates.

Less likely to help

People with very large or diffuse brain damage, unstable medical conditions, or who are not eligible for an invasive injection procedure may not receive benefit from this approach.

What this research studies

This project is developing an injectable, brain-like nanocomposite hydrogel that could be placed into the area damaged by stroke to help guide repair. The material is built to copy the brain's natural scaffold while encouraging new blood vessel growth and calming inflammation. Researchers will test how the gel supports tissue, steers immune cells, and helps regrowth in lab and animal studies before any human use. The aim is a single injectable material that provides physical support, biological signals, and immune control to improve recovery after stroke.

Why it matters

Potential benefit: If successful, the approach could help restore damaged brain tissue and improve functional recovery after stroke by promoting blood vessel regrowth and reducing harmful inflammation.

How similar studies have gone: Related preclinical work using angiogenic or anti-inflammatory hydrogels has shown partial tissue repair but has not yet produced full functional recovery in humans.

Where this research is happening

  • University of Nevada Las Vegas
    Las Vegas, United States
    Active

Researchers

  • Principal investigator: NIH, Lina R. — University of Nevada Las Vegas
  • Study coordinator: NIH, Lina R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.